e-Drug3D

2168

ETRIPAMIL


INN
ETRIPAMIL

cas 1593673-23-4
CLASS

CARDIOVASCULAR
L-TYPE CALCIUM INFLUX INHIBITOR (SLOW CHANNEL BLOCKER OR CALCIUM ION ANTAGONIST)

ROUTE (list)

NASAL

ATC code

C08DA03

PK parameters

Tmax 0.12 HOUR
VD 2850 LITER
PPB 50 PERCENT
t1/2 2.5 HOUR

Solubility

INSOLUBLE IN WATER


Target

TARGET CALCIUM CHANNEL

DrugCentral

-

Download SDF file Benzoic acid, 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]-, methyl ester

Formula:
C27H36N2O4

Calculated chemical properties:

MW 452.58
NB_atoms 33
XLogP 4.86
PSA 71.904
NB_HD 0
NB_HA 6
fsp3 0.48
Lipinski(0=no;1=yes) 1

FDA
NDA 218571 (label) INN (ETRIPAMIL) CARDAMYST (MILESTONE PHARMS USA) APPROVAL= AP YEAR= 2025 NEWMOLECULARENTITY

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL